(+-)-3-Quinuclidinol → (Rac.)-3-[6-(4-fluorophenyl)-pyridazin-3-yloxy]-1-aza-bicyclo[2.2.2]octane
反応式
[N:1]12[CH2:8][CH2:7][CH:4]([CH2:5][CH2:6]1)[CH:3]([OH:9])[CH2:2]2.[H-].[Na+].Cl[C:13]1[N:14]=[N:15][C:16]([C:19]2[CH:24]=[CH:23][C:22]([F:25])=[CH:21][CH:20]=2)=[CH:17][CH:18]=1>C1COCC1>[F:25][C:22]1[CH:21]=[CH:20][C:19]([C:16]2[N:15]=[N:14][C:13]([O:9][CH:3]3[CH:4]4[CH2:7][CH2:8][N:1]([CH2:6][CH2:5]4)[CH2:2]3)=[CH:18][CH:17]=2)=[CH:24][CH:23]=1参加物
実験手順
A solution of (rac.)-3-quinuclidinol (0.007 mole) in dry THF under nitrogen is treated with sodium hydride (60% in mineral oil; 1.1 equiv.). After 1 hr at room temperature, a solution of 3-chloro-6-(4-fluoro-phenyl)pyridazine (1.0 equiv.) in THF (30 ml) is added, and the reaction mixture heated to reflux for 6 hrs. After cooling to rt, the THF is evaporated and the residue dissolved in ethyl acetate (100 ml) and then washed with water (3×20 ml), followed by sodium chloride solution (20 ml). The ethyl acetate is dried over anhydrous magnesium sulfate, filtered and evaporated to dryness, and the residual oil purified by silica gel column chromatography (eluent: ethyl acetate-methanol-triethylamine (50:10:2) to afford (rac.)-3-[6-(4-fluorophenyl)-pyridazin-3-yloxy]-1-aza-bicyclo[2.2.2]octane as a colourless solid. 1H-NMR (400 MHz, CDCl3): δ=8.00 (m, 2H), 7.75 (d, 1H), 7.17 (m, 2H), 7.1 (d, 1H), 5.35 (m, 1H), 3.5 (m, 1H), 2.99-2.83 (m, 5H), 2.32 (m, 1H), 1.98 (m, 1H), 1.76-1.68 (m, 2H), 1.46 (m, 1H).
後処理
- temperaturethe reaction mixture heated
- temperatureto reflux for 6 hrs
- customthe THF is evaporated
- dissolutionthe residue dissolved in ethyl acetate (100 ml)
- washwashed with water (3×20 ml)
- dry with materialThe ethyl acetate is dried over anhydrous magnesium sulfate
- filtrationfiltered
- customevaporated to dryness
- customthe residual oil purified by silica gel column chromatography (eluent
出典と根拠
- ORDレコード
- ord-187224bd1ffc4fc39d40007a6fbde82b
- 出典データセット
- uspto-grants-2012_08
- 特許番号
- US08236803B2
反応ノート
読み込み中…